Control programs for infectious bovine rhinotracheitis (IBR) in European countries: an overview

Anim Health Res Rev. 2021 Dec;22(2):136-146. doi: 10.1017/S1466252321000116.

Abstract

Infectious bovine rhinotracheitis (IBR), caused by Bovine alphaherpesvirus 1 (BoHV-1), is a disease of cattle responsible for significant economic losses worldwide. IBR is under certain communitarian regulations. Every member state can approve its own national IBR control program for the entire territory - or part of it - and can demand additional guarantees for bovids destined to its territory; therefore, every member state can be officially declared as entirely or partly IBR-free. The aim of this review is to provide an overview of IBR control and eradication programs in European countries. BoHV-1 control schemes were first introduced in the late 1970s, mainly in Northern and Central Europe. Depending on the seroprevalence rate, control strategies rely on identification and removal of seropositive animals or the use of glycoprotein E (gE)-deleted marker vaccines in infected herds. The implementation of a novel law for disease eradication at the EU level and of a European IBR data flow could make the goal of IBR eradication in all European countries easier to achieve.

Keywords: Control program; Europe; IBR; eradication.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antibodies, Viral
  • Cattle
  • Cattle Diseases* / epidemiology
  • Cattle Diseases* / prevention & control
  • Europe / epidemiology
  • Herpesvirus 1, Bovine*
  • Infectious Bovine Rhinotracheitis* / epidemiology
  • Infectious Bovine Rhinotracheitis* / prevention & control
  • Seroepidemiologic Studies

Substances

  • Antibodies, Viral